229 related articles for article (PubMed ID: 17261983)
21. Prognosis of gastrointestinal stromal tumors.
Bertin M; Angriman I; Scarpa M; Mencarelli R; Ranzato R; Ruffolo C; Polese L; Iacobone M; D'Amico DF
Hepatogastroenterology; 2007; 54(73):124-8. PubMed ID: 17419245
[TBL] [Abstract][Full Text] [Related]
22. Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: markers with potential prognostic implications.
Sabah M; Cummins R; Leader M; Kay E
Hum Pathol; 2006 Jun; 37(6):648-55. PubMed ID: 16733203
[TBL] [Abstract][Full Text] [Related]
23. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.
Miettinen M; Wang ZF; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013
[TBL] [Abstract][Full Text] [Related]
24. [Roles of risk assessment and Ki-67 index in judging prognostic of gastrointestinal stromal tumors].
Liang YM; Li XH; Chen W
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1041-5. PubMed ID: 18754437
[TBL] [Abstract][Full Text] [Related]
25. The utility of fine-needle aspiration in the diagnosis of gastrointestinal stromal tumors: a cytomorphologic and immunohistochemical analysis with emphasis on malignant tumors.
Elliott DD; Fanning CV; Caraway NP
Cancer; 2006 Feb; 108(1):49-55. PubMed ID: 16130141
[TBL] [Abstract][Full Text] [Related]
26. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
Zheng S; Chen LR; Wang HJ; Chen SZ
Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649
[TBL] [Abstract][Full Text] [Related]
27. Gastrointestinal stromal tumors (GISTs): analysis of 20 cases.
Bölükbasi H; Nazli O; Tansug T; Bozdag AD; Isgiider AS; Yaman I; Haciyanli M; Genc H
Hepatogastroenterology; 2006; 53(69):385-8. PubMed ID: 16795978
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade.
Nakamura N; Yamamoto H; Yao T; Oda Y; Nishiyama K; Imamura M; Yamada T; Nawata H; Tsuneyoshi M
Hum Pathol; 2005 Jul; 36(7):828-37. PubMed ID: 16084954
[TBL] [Abstract][Full Text] [Related]
29. Expression of stem cell factor (SCF), a KIT ligand, in gastrointestinal stromal tumors (GISTs): a potential marker for tumor proliferation.
Hirano K; Shishido-Hara Y; Kitazawa A; Kojima K; Sumiishi A; Umino M; Kikuchi F; Sakamoto A; Fujioka Y; Kamma H
Pathol Res Pract; 2008; 204(11):799-807. PubMed ID: 18602222
[TBL] [Abstract][Full Text] [Related]
30. The cyclin-dependent kinase inhibitor, p27, has no correlation with the malignant potential of GIST.
Shirin H; Kravtsov V; Shahmurov M; Shabat VS; Krinshpon I; Alin A; Avinoach I; Avni Y
Digestion; 2007; 75(1):4-9. PubMed ID: 17406118
[TBL] [Abstract][Full Text] [Related]
31. Multiple sporadic gastrointestinal stromal tumors (GISTs) of the proximal stomach are caused by different somatic KIT mutations suggesting a field effect.
Agaimy A; Dirnhofer S; Wünsch PH; Terracciano LM; Tornillo L; Bihl MP
Am J Surg Pathol; 2008 Oct; 32(10):1553-9. PubMed ID: 18724245
[TBL] [Abstract][Full Text] [Related]
32. [A clinicopathological study on 107 cases with gastrointestinal stromal tumors].
Wang M; Cao H; Ni XZ; Lin W; Zhuang J; Shen ZY; Chen ZP; Wu ZY; Yin XL
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jan; 10(1):39-42. PubMed ID: 17253172
[TBL] [Abstract][Full Text] [Related]
33. Malignant potential of gastrointestinal stromal tumor of the stomach.
Aoyagi K; Kouhuji K; Yano S; Miyagi M; Imaizumi T; Takeda J; Shirouzu K
Int Surg; 2009; 94(1):1-9. PubMed ID: 20099418
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of Ki-67 and p53 expression in primary and repeated liver metastases of GISTs.
Gunji Y; Nikaidou T; Okazumi S; Matsubara H; Shimada H; Nabeya Y; Aoki T; Makino H; Miyazaki S; Ochiai T
Hepatogastroenterology; 2005; 52(63):829-32. PubMed ID: 15966214
[TBL] [Abstract][Full Text] [Related]
35. High incidence of microscopic gastrointestinal stromal tumors in the stomach.
Kawanowa K; Sakuma Y; Sakurai S; Hishima T; Iwasaki Y; Saito K; Hosoya Y; Nakajima T; Funata N
Hum Pathol; 2006 Dec; 37(12):1527-35. PubMed ID: 16996566
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of p53 gene mutations and protein overexpression in localized gastrointestinal stromal tumours.
Ryu MH; Kang YK; Jang SJ; Kim TW; Lee H; Kim JS; Park YH; Lee SS; Ryoo BY; Chang HM; Lee JL; Yook JH; Kim BS; Lee JS
Histopathology; 2007 Sep; 51(3):379-89. PubMed ID: 17727479
[TBL] [Abstract][Full Text] [Related]
37. Multicentric sporadic gastrointestinal stromal tumors (GISTs) of the stomach with distinct clonal origin: differential diagnosis to familial and syndromal GIST variants and peritoneal metastasis.
Haller F; Schulten HJ; Armbrust T; Langer C; Gunawan B; Füzesi L
Am J Surg Pathol; 2007 Jun; 31(6):933-7. PubMed ID: 17527083
[TBL] [Abstract][Full Text] [Related]
38. Incidental finding of gastrointestinal stromal tumors (GISTs) during laparoscopic gastric bypass.
Sanchez BR; Morton JM; Curet MJ; Alami RS; Safadi BY
Obes Surg; 2005; 15(10):1384-8. PubMed ID: 16354516
[TBL] [Abstract][Full Text] [Related]
39. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).
Dematteo RP; Gold JS; Saran L; Gönen M; Liau KH; Maki RG; Singer S; Besmer P; Brennan MF; Antonescu CR
Cancer; 2008 Feb; 112(3):608-15. PubMed ID: 18076015
[TBL] [Abstract][Full Text] [Related]
40. Coexpression of cyclooxygenase-2 and vascular endothelial growth factor in gastrointestinal stromal tumor: possible relations to pathological parameters and clinical behavior.
Miao R; Liu N; Wang Y; Li L; Yu X; Jiang Y; Li J
Hepatogastroenterology; 2008; 55(88):2012-5. PubMed ID: 19260469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]